|
[1]CHEN DJ, LIU XY.Diagnosis and emergency treatment of severe hepatitis during pregnancy[J].J Pract Obstet Gynecol, 2010, 26 (4) :249-252. (in Chinese) 陈敦金, 刘晓燕.妊娠合并重症肝炎的诊断和急救[J].实用妇产科杂志, 2010, 26 (4) :249-252.
|
|
[2] PUNZALAN CS, BARRY CT.Acute liver failure:Diagnosis and management[J].J Intensive Care Med, 2016, 31 (10) :642-653.
|
|
[3]JIANG PR, QIU SX.Analysis of 2137 cases of liver diseases in pregnant women[J].Chin Hepatol, 2006, 11 (4) :247-248. (in Chinese) 蒋佩茹, 邱申熊.妊娠期肝病2137例临床分析[J].肝脏, 2006, 11 (4) :247-248.
|
|
[4]DIAO JC, GAN N.Abnormal liver function and relationship with pregnancy complications or influence of perinatals[J].Anhui Med J, 2011, 32 (6) :782-784. (in Chinese) 刁俊春, 干宁.肝功能异常与妊娠并发症的关系及对围生儿的影响[J].安徽医学, 2011, 32 (6) :782-784.
|
|
[5]MALLERY S, van DAM J.Advances in diagnostic and therapeutic endoscopy[J].Med Clin North Am, 2000, 84 (5) :1059-1083.
|
|
[6]ZHENG Y, LI YG.Research advances in predisposing factors for acute-on-chronic hepatitis B liver failure[J].J Clin Hepatol, 2017, 33 (9) :1802-1805. (in Chinese) 郑颖, 李用国.乙型肝炎相关慢加急性肝衰竭诱因的研究进展[J].临床肝胆病杂志, 2017, 33 (9) :1802-1805.
|
|
[7]YANG YB, LI XM, SHI ZJ, et al.Pregnant woman with fulminant hepatic failure caused by hepatitis B virus infection:A case report[J].World J Gastroenterol, 2004, 10 (15) :2305-2306.
|
|
[8]TANG WL, XIE Q.Advance in antiviiral treatment of hepadtitis B virus-related liver failure[J].Chin J Hepatol, 2012, 20 (6) :408-410. (in Chinese) 汤伟亮, 谢青.乙型肝炎相关肝衰竭抗病毒治疗研究进展[J].中华肝脏病杂志, 2012, 20 (6) :408-410.
|
|
[9]WANG YM, TANG YZ.Antiviral therapy for hepatitis B virus associated hepatic failure[J].Hepatobiliary Pancreat Dis Int, 200, 8 (1) :17-24.
|
|
[10]ZHUANG QY, LIU M, FU D, et al.The postpartum changes of liver function after telbivuding treatment in preventing mother-to Child transmission of hepatitis B virus infection during pregnancy[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition, 2016, 10 (3) :337-341. (in Chinese) 庄虔莹, 刘敏, 付冬, 等.孕期服用替比夫定进行乙型肝炎母婴阻断的产后肝功能观察[J/CD].中华实验和临床感染病杂志:电子版, 2016, 10 (3) :337-341.
|
|
[11]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
|
|
[12]SHARON A, CHU CK.Understanding the molecular basis of HBV drug resistance by molecular modeling[J].Antiviral Res, 2008, 80 (3) :339-353.
|
|
[13] ZHAO S, TANG L, FAN X, et al.Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B:A systematic review[J].Virol J, 2010, 7:211.
|
|
[14]SI H, JIA Q, DING QS.Comparative study on the clinical efficacy of entecavir and telbivudine for chronic hepatitis B[J].Int J Virol, 2016, 23 (3) :203-206. (in Chinese) 司华, 贾琦, 丁曲顺.恩替卡韦与替比夫定对慢性乙型病毒性肝炎的临床疗效比较研究[J].国际病毒学杂志, 2016, 23 (3) :203-206.
|
|
[15] MIYAKE Y, IWASAKI Y, TAKAKI A, et al.Lamivudine treatment improves the prognosis of fulminant hepatitis B[J].Intern Med, 2008, 47 (14) :1293-1299.
|
|
[16] DELIC'D, NESIC'Z, PROSTRAN M, et al.Treatment of subacute hepatitis B with lamivudine:A pilot study in Serbia[J].Vojnosanit Pregl, 2009, 66 (3) :199-202.
|
DownLoad: